ICAM-1 promotes T cell glycolytic reprogramming and tumor infiltration to drive 18F-FDG PET flares following radiotherapy
Protein & Cell · 2026
DOI: 10.1093/procel/pwaf111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein & Cell, 2026. Verfasst von Rui Song und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Peking University Cancer Hospital and Department of Radiation Medicine, School of Basic Medical Sciences, Peking Univ…. Hauptthemen laut MEDLINE: Intercellular Adhesion Molecule-1, Fluorodeoxyglucose F18, Glycolysis, Positron-Emission Tomography. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Beijing Natural Science Foundation.
Abstract (Originalsprache)
18F-fluorodeoxyglucose (18F-FDG) is the most widely used radiotracer for positron emission tomography (PET) imaging in clinical oncology, owing to the elevated glycolytic activity of tumor cells. However, transient post-radiotherapy (RT) “metabolic flares” of 18F-FDG uptake are frequently observed in patients and are traditionally attributed to localized inflammatory responses. Whether these flares are linked to immune cell dynamics, particularly tumor-infiltrating T cells, and the mechanisms involved remain poorly understood. Here, we demonstrate that RT markedly upregulates intracellular adhesion molecule-1 (ICAM-1) expression and promotes T cell infiltration in tumors, as observed in both patients and mouse models. Genetic ablation of ICAM-1 significantly attenuates RT-induced metabolic flares in irradiated tumors, primarily due to reduced 18F-FDG uptake by tumor-infiltrating T cells rather than myeloid cells. Mechanistically, ICAM-1 engages with lymphocyte function-associated antigen 1 (LFA-1) to facilitate T cell clustering, thereby promoting their intratumoral accumulation and activating glycolysis and the tricarboxylic acid cycle via the PI3K-AKT-mTOR signaling pathway. These findings identify ICAM-1 as a critical regulator of T cell metabolic reprogramming and tumor infiltration following RT, offering a mechanistic explanation for 18F-FDG PET flares. Clinical monitoring of post-RT tumor ICAM-1 expression may enhance PET interpretation and aid in distinguishing pseudoprogression from true tumor progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Peking University Cancer Hospital and Department of Radiation Medicine, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
- State Key Laboratory of Vascular Homeostasis and Remodeling, Department of Nuclear Medicine, Peking University Third Hospital, Beijing 100191, China.
- Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China.
- Department of Pathology, Peking University Third Hospital, Beijing 100191, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Peking Uni…
- Department of Cell Biology, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
ORCID-Profile: Rui Song, Ting Zhang, Fuxin Guo, Jinhong Du, Jiadong Wang, Zhi Yang, Zhaofei Liu
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Peking University Medicine plus X Pilot Program-Key Technologies R&D Project
- Key Clinical Projects of Peking University Third Hospital
- Peking University Cancer Hospital Science Research Fund
Zitieren
APA
Song, R., Zhao, M., Zhang, T., Zhang, Y., Guo, F., He, H., Zhou, H., Li, K., Wang, J., Du, J., Wang, F., Zhou, S., Zhu, H., Wang, J., Zhang, W., Yang, Z., & Liu, Z. (2026). ICAM-1 promotes T cell glycolytic reprogramming and tumor infiltration to drive 18F-FDG PET flares following radiotherapy. Protein & Cell. https://doi.org/10.1093/procel/pwaf111
Vancouver
Song R, Zhao M, Zhang T, Zhang Y, Guo F, He H, et al. ICAM-1 promotes T cell glycolytic reprogramming and tumor infiltration to drive 18F-FDG PET flares following radiotherapy. Protein & Cell. 2026. doi:10.1093/procel/pwaf111
BibTeX
@article{Song2026,
author = {Song, Rui and Zhao, Meixin and Zhang, Ting and Zhang, Yining and Guo, Fuxin and He, Huiying and Zhou, Haoyi and Li, Kui and Wang, Jianze and Du, Jinhong and Wang, Feng and Zhou, Shixin and Zhu, Hua and Wang, Jiadong and Zhang, Weifang and Yang, Zhi and Liu, Zhaofei},
title = {ICAM-1 promotes T cell glycolytic reprogramming and tumor infiltration to drive 18F-FDG PET flares following radiotherapy},
journal = {Protein & Cell},
year = {2026},
doi = {10.1093/procel/pwaf111}
}
EUVIMED